Tus kws kho mob
QP17-16 Claims with Attachments
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 26, 2016
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 3291 - 3300 ntawm 4138
Tus kws kho mob
QP100-18 Pharmacy Benefit Exclusion for Crinone (progesterone) Gel, Finacea (alzelaic acid) Foam, Glatopa (glatiramer acetate) Injection
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 28, 2018
Tus kws kho mob
QP1-18 Transition of Care Management Features for New Medicare Advantage Prescription Drug Plans
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 08, 2018
Tus kws kho mob
QP11-16 New BlueRide Email Notification Option for SNF
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 04, 2016
Tus kws kho mob
QP44-17 New Pre-Authorization Form for Botulinum Toxin for Commercial Products
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 05, 2017
Tus kws kho mob
QP12-17 Prior Authorization/Pre-Approval Forms Specific to Select Medical Policies
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 31, 2017
Tus kws kho mob
QP32-16 Centurion Contracts with BlueLink TPA for Claims Administration Servicesa
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 18, 2016
Tus kws kho mob
QP34-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Uric Acid Transport 1 (URAT1) Inhibitor
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 15, 2018
Tus kws kho mob
QP42-16 Pharmacy Step Therapy Program Name Change for Anticonvulsant Agents and Update on Drugs Subject to This Step Therapy Program
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 15, 2016
Tus kws kho mob
QP22-16 APR-DRG and EAPG Grouper Updates
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 02, 2016